Furrukh Malik is a Cardiology physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 18 publications with 342 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372328010
Telephone
615-322-3000Provider last certified this registry record 4 Jun 2026.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.4%Beta blocker13.4%Carvedilol40%Metoprolol Succinate29%Metoprolol Tartrate24%Atenolol7%Part D≥68 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)10.8%Entresto100%Part D≥107 patients+ 16 more classes in this area
Metabolism & gastrointestinal
20.7%SGLT2 inhibitor19.4%Jardiance90%Farxiga10%Part D≥174 patientsPotassium supplement0.7%Potassium Chloride100%Part D≥12 patients+ 2 more classes in this area
Blood & clotting
8.5%Factor Xa inhibitor7.2%Eliquis64%Xarelto36%Part D≥60 patientsP2Y12 inhibitor1.3%Clopidogrel100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Unlikely Culprit of Hospital-Acquired Warfarin Resistance: A Case Report and Review of Literature
International Medical Case Reports Journal
2026 - IMPACT OF LVEDP ON RESPONSE AND SAFETY OF HIGH-DOSE HYDRATION POLICY TO PREVENT AKI POST-PCI : A SINGLE-CENTER 4-YEAR EXPERIENCE
Journal of the American College of Cardiology
2023 - Metabolic Syndrome and Related Inflammation, Prevalence, and Predictive Value of C-Reactive Protein in South Asian Youths
Metabolic Syndrome and Related Disorders
2021 - Trichobezoer: An Unusual Presentation with Congestive Heart Failure
HCA Healthcare Journal of Medicine
2021 - A rare case of exertional angina in an adult due to anomalous origin of the circumflex artery from the right main pulmonary artery.
PubMed
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”